11.11.2009 • News

Linde Sees Further Recovery In H2

Linde says H1 operating margin increases to 20.2 % despite ­restructuring costs. The company said H1 improved operating cash flow: €841 million (2008: €816 million). Group sales are down 12.5 % to €5.476 billion. Second-quarter sales of €2.781 billion versus €3.339 billion, and second-quarter operating profit €566 million versus €656 million. The company said further recovery in business trends is expected compared with the first half of the year; however, 2008 record level is no longer attainable.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.